Rhumbline Advisers lifted its stake in shares of Davita Inc (NYSE:DVA) by 1.3% during the 4th quarter, HoldingsChannel.com reports. The institutional investor owned 325,210 shares of the company’s stock after buying an additional 4,055 shares during the period. Rhumbline Advisers’ holdings in Davita were worth $23,496,000 at the end of the most recent quarter.
Several other hedge funds and other institutional investors also recently made changes to their positions in the stock. Raymond James Financial Services Advisors Inc. increased its position in shares of Davita by 196.5% during the fourth quarter. Raymond James Financial Services Advisors Inc. now owns 18,710 shares of the company’s stock valued at $1,352,000 after buying an additional 12,399 shares during the period. Twin Tree Management LP purchased a new stake in Davita in the fourth quarter worth about $900,000. Arizona State Retirement System grew its holdings in Davita by 4.1% in the fourth quarter. Arizona State Retirement System now owns 107,234 shares of the company’s stock worth $7,748,000 after purchasing an additional 4,186 shares during the period. Capital Fund Management S.A. purchased a new stake in Davita in the fourth quarter worth about $2,651,000. Finally, State of Wisconsin Investment Board grew its holdings in Davita by 50.6% in the fourth quarter. State of Wisconsin Investment Board now owns 127,470 shares of the company’s stock worth $9,210,000 after purchasing an additional 42,815 shares during the period. Institutional investors own 82.88% of the company’s stock.
DVA has been the topic of a number of recent research reports. Raymond James Financial upgraded shares of Davita from an “outperform” rating to a “strong-buy” rating and upped their price objective for the stock from $65.00 to $84.00 in a report on Thursday, December 7th. Royal Bank of Canada cut their price objective on shares of Davita from $64.00 to $60.00 and set a “sector perform” rating on the stock in a report on Wednesday, November 8th. Bank of America upgraded shares of Davita from a “neutral” rating to a “buy” rating and upped their price objective for the stock from $75.00 to $85.00 in a report on Thursday, January 4th. Robert W. Baird restated a “hold” rating and issued a $63.00 price objective on shares of Davita in a report on Friday, November 10th. Finally, KeyCorp restated a “hold” rating on shares of Davita in a report on Monday, November 13th. Two research analysts have rated the stock with a sell rating, five have given a hold rating, four have given a buy rating and two have given a strong buy rating to the stock. The company currently has a consensus rating of “Hold” and an average price target of $79.30.
In other news, insider Charles Berg sold 7,048 shares of the company’s stock in a transaction that occurred on Monday, December 11th. The shares were sold at an average price of $69.24, for a total value of $488,003.52. Following the transaction, the insider now owns 5,359 shares in the company, valued at $371,057.16. The sale was disclosed in a legal filing with the SEC, which is available at this link. Also, CEO Javier Rodriguez sold 22,532 shares of the company’s stock in a transaction that occurred on Thursday, December 7th. The stock was sold at an average price of $67.48, for a total transaction of $1,520,459.36. Following the completion of the transaction, the chief executive officer now owns 210,317 shares in the company, valued at approximately $14,192,191.16. The disclosure for this sale can be found here. In the last quarter, insiders sold 121,509 shares of company stock worth $8,310,388. Insiders own 2.10% of the company’s stock.
Davita Inc (NYSE:DVA) opened at $72.07 on Friday. The stock has a market cap of $13,237.64, a P/E ratio of 21.09, a PEG ratio of 1.56 and a beta of 0.99. Davita Inc has a 52 week low of $52.51 and a 52 week high of $80.71. The company has a quick ratio of 2.82, a current ratio of 2.88 and a debt-to-equity ratio of 1.87.
Davita (NYSE:DVA) last issued its earnings results on Tuesday, February 13th. The company reported $0.92 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.94 by ($0.02). The firm had revenue of $2.78 billion during the quarter, compared to the consensus estimate of $3.90 billion. Davita had a return on equity of 12.86% and a net margin of 4.65%. During the same quarter in the prior year, the company posted $0.98 EPS. research analysts forecast that Davita Inc will post 4.18 EPS for the current year.
TRADEMARK VIOLATION NOTICE: “Davita Inc (DVA) Shares Bought by Rhumbline Advisers” was first published by Dispatch Tribunal and is the sole property of of Dispatch Tribunal. If you are reading this piece of content on another domain, it was illegally copied and reposted in violation of U.S. and international copyright & trademark legislation. The correct version of this piece of content can be viewed at https://www.dispatchtribunal.com/2018/02/23/davita-inc-dva-shares-bought-by-rhumbline-advisers.html.
DaVita Inc, formerly DaVita HealthCare Partners Inc, operates two divisions: DaVita Kidney Care (Kidney Care) and DaVita Medical Group (DMG). The Kidney Care division consists of its the United States dialysis and related lab services, its ancillary services and strategic initiatives, including its international operations, and its corporate administrative support.
Want to see what other hedge funds are holding DVA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Davita Inc (NYSE:DVA).
Receive News & Ratings for Davita Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Davita and related companies with MarketBeat.com's FREE daily email newsletter.